ASPIRO FDA Approval ANDA 214616

ANDA 214616

ASPIRO

FDA Drug Application

Application #214616

Application Sponsors

ANDA 214616ASPIRO

Marketing Status

Prescription001

Application Products

001POWDER;INTRAVENOUSEQ 150MG BASE/VIAL0FOSAPREPITANT DIMEGLUMINEFOSAPREPITANT DIMEGLUMINE

FDA Submissions

UNKNOWN; ORIG1AP2021-07-29STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAP

CDER Filings

ASPIRO
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214616
            [companyName] => ASPIRO
            [docInserts] => ["",""]
            [products] => [{"drugName":"FOSAPREPITANT DIMEGLUMINE","activeIngredients":"FOSAPREPITANT DIMEGLUMINE","strength":"EQ 150MG BASE\/VIAL","dosageForm":"POWDER;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"07\/29\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-07-29
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.